Key Takeaways
- Wolfe Research elevated GM from Peer Perform to Outperform, establishing a $96 price objective
- Auto sector equities declined approximately 8% during the preceding three-week period amid macroeconomic uncertainty
- Analysts identify 2027 catalysts for GM: full-size truck redesign valued at approximately $1.7B, warranty expense reductions, and tariff relief
- Wolfe forecasts GM earnings per share at $12.37 for 2026, climbing to $16.03 in 2027
- Ford received cautionary assessment due to potential $1.5B EBIT pressure in 2027 from inventory concerns
Wolfe Research elevated General Motors to an Outperform rating this Wednesday, establishing a $96 price objective for the automaker. This represents an advancement from the firm’s previous Peer Perform designation.
The rating enhancement arrives amid widespread weakness across automotive equities during recent weeks. Average sector valuations contracted roughly 8% as macroeconomic anxieties weighed on investor sentiment.
Emmanuel Rosner, the covering analyst, observed that automotive stocks typically rank “among the main targets when macro concerns escalate.” However, he emphasized that historical patterns reveal these selloffs “can also present interesting buying opportunities.”
Following a comprehensive revision of production forecasts and commodity price trajectories, Wolfe concluded the “risk/reward profile now appears more attractive for select names.” GM emerged as the firm’s preferred choice within this framework.
The research house contends that market participants may be overlooking the magnitude of GM’s prospective earnings growth through 2027. Central to this thesis stands the forthcoming redesign of full-size pickups, which Wolfe quantifies at approximately $1.7 billion in incremental value.
Warranty-related expenditures face anticipated declines. Additionally, Wolfe anticipates a diminished net tariff impact and ongoing progress in reducing electric vehicle segment losses as supplementary positive factors.
Wolfe currently projects GM will deliver earnings of $12.37 per share during 2026, advancing to $16.03 throughout 2027. The 2027 projection represents where the firm identifies the most significant market mispricing.
BorgWarner and Aptiv Receive Positive Assessments
Wolfe simultaneously upgraded BorgWarner to Outperform within the same research publication. The firm highlighted the organization’s “Power Gen opportunity,” estimating it could contribute approximately $2 billion in revenues at full deployment.
Rosner indicated the stock’s recent decline means this growth potential remains unrecognized by current valuations. Wolfe characterizes the current setup as appealing.
Regarding Aptiv, Rosner maintained his constructive outlook in advance of the company’s forthcoming separation. He described the present moment as “a compelling entry point,” referencing robust underlying fundamentals across both entities that will emerge from the corporate division.
Ford Receives Measured Assessment
The sector review included cautionary notes for certain manufacturers. Wolfe identified execution challenges at Ford, highlighting ambiguity surrounding the 2026 production schedule.
The firm expressed concern that elevated year-end inventory levels could generate a $1.5 billion EBIT headwind extending into 2027. Rosner maintained his previous stance on Ford without implementing an upgrade.
The Wolfe analysis demonstrates a discriminating perspective on the automotive sector rather than blanket optimism. GM’s updated truck portfolio and operational cost enhancements formed the foundation of the upgrade rationale.
Wolfe’s 2027 EPS projection of $16.03 for GM exceeds prevailing consensus estimates considerably, indicating the firm identifies substantial appreciation potential should these anticipated catalysts develop as projected.
